Clinical Evaluation of the Oncology Malignancies by Using Biosensors
Abstract
Full Text:
PDFReferences
Ronkainen N.J. Nanomaterial-based electrochemical immunosensors for clinically significant biomarkers, Open Acess J. 2014; 7: 4669–9p. 2. Hasan A., Memic A., Annabi N. “Electrospin scaffolds for tissue engineering of vascular grafts,”Acta Biomater. 2014; 10: 11–25p.
Ottou F.G. Peripheralblood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high‐risk patients, Wiley Online J. 2014; 8: 54–75p.
Wilson M.S., Nie W, Multiplex measurement of seven tumor markers using an electrochemical protein chip, Anal. Chem. 2006; 78: 6476–83p.
Wu J., Yan F., Tang J., et al. A disposable multianalyte electrochemical immunosensor array for automated simultaneous determination of tumor markers, Clin Chem. 2007; 1495–1502p.
Pimková K., Bocková M., Hegnerová K., et al. Surface plasmon resonance biosensor for the detection of VEGFR-1 – A protein marker of
myelodysplastic syndromes, Anal Bioanal Chem. 2012; 402: 381–7p.
Rasooly A., Jacobson J. Development of biosensors for cancer clinical testing, Biosens Bioelectron. 2006; 21; 1851–8p.
Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis, J Biochem Mol Biol. 2006; 39; 469–78p.
Medley C.D., Smith J.E., Tang Z., et al. Nanoparticle-based colorimetric assay for the direct detection of cancerous cells, Anal Chem. 2008; 80: 1067–72p.
Herzenberg L.A., Parks D., Sahaf B., et al. The historyand future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford, Clin Chem. 48: 1819–27p.
Chabanas A., Rambeaud J.J., Huo H.H., et al. Limits of flow-cytometry histogram analysis methods to assess bladder tumour antigen expression, Anal Cell Pathol. 1997; 13; 39–47p.
Piatkowska-Jakubas B., Krawczyk-Kuliś M., Giebel S., et al. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group, Pol Arch Med Wewn. 2008; 118: 664–9p.
Hiddemann W., Buchner T. Current status and perspectives of therapies for acute myeloid leukaemia, Semin Hematol. 2001; 38: 3–9p.
Alloush H.M., Anderson E., Martin A.D., et al. A bioluminescent microbial biosensor for in vitro pretreatment assessment of cytarabine efficacy in leukemia, Clin Chem. 2010; 56: 1862–70p.
Mizutani T., Kondo T., Darmanin S., et al. Novel FRET-based biosensor for the measurement of BCR-ABL activity and its response to drugs in living cells, Clin Cancer Res. 2010; 16: 3964–75p.
Refbacks
- There are currently no refbacks.